Alessandro Re Selected Research

Alessandro Re Research Topics

Disease

18	Lymphoma (Lymphomas) 02/2023 - 12/2003
17	Hodgkin Disease (Hodgkin's Disease) 11/2023 - 12/2002
7	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023 - 01/2019
6	Neoplasms (Cancer) 01/2023 - 08/2009
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 03/2017
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2023 - 01/2021
5	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2022 - 01/2019
4	B-Cell Lymphoma (Lymphoma, B Cell) 02/2024 - 01/2021
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 09/2005
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 08/2009
4	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 08/2009 - 09/2005
3	Cytopenia 01/2023 - 07/2002
3	Infections 01/2021 - 07/2002
3	Neutropenia 03/2017 - 06/2006
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2022 - 11/2022
2	Leukemia 12/2019 - 05/2014
1	Fever (Fevers) 04/2023
1	Body Weight (Weight, Body) 04/2023
1	Pathologic Complete Response 11/2022
1	Hematologic Diseases (Blood Diseases) 10/2022
1	Obesity 03/2022
1	Vitamin D Deficiency 03/2022
1	Mycoses (Diseases, Fungus) 01/2021
1	Thrombotic Thrombocytopenic Purpura 01/2021
1	Mucositis 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Splenic Diseases 01/2019
1	Vomiting 03/2017
1	Febrile Neutropenia 03/2017
1	Stroke (Strokes) 03/2017
1	Infarction (Infarctions) 03/2017
1	Melena 03/2017
1	Invasive Fungal Infections 06/2015
1	Plasmablastic Lymphoma 12/2014
1	Sepsis (Septicemia) 05/2014

Drug/Important Bio-Agent (IBA)

8	Rituximab (Mabthera)FDA Link 02/2024 - 06/2006
6	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 08/2015
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020 - 01/2019
5	Bleomycin (Blenoxane)FDA LinkGeneric 11/2023 - 08/2015
5	Vinblastine (Vinblastine Sulfate)FDA Link 11/2023 - 08/2015
5	Dacarbazine (DIC)FDA LinkGeneric 11/2023 - 08/2015
4	Lenalidomide (CC 5013)FDA Link 01/2023 - 03/2017
3	Vincristine (Oncovin)FDA LinkGeneric 02/2024 - 11/2022
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 11/2022
3	Prednisone (Sone)FDA LinkGeneric 02/2024 - 11/2022
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
3	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2021 - 01/2019
2	Etoposide (VP 16)FDA LinkGeneric 11/2023 - 02/2021
2	romidepsin (FK228)FDA Link 01/2023 - 01/2022
2	Brentuximab VedotinIBA 10/2020 - 12/2015
1	Procarbazine (Matulane)FDA Link 11/2023
1	isatuximabIBA 02/2023
1	Programmed Cell Death 1 ReceptorIBA 02/2023
1	cemiplimabIBA 02/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 12/2022
1	Docosahexaenoic AcidsIBA 03/2022
1	Vitamin D FDA LinkGeneric 03/2022
1	VaccinesIBA 01/2022
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 02/2021
1	Ifosfamide FDA LinkGeneric 02/2021
1	Carboplatin (JM8)FDA LinkGeneric 02/2021
1	SolutionsIBA 02/2021
1	Carmustine (FIVB)FDA Link 02/2021
1	Saline SolutionIBA 02/2021
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 02/2021
1	Mesna (Coenzyme M)FDA LinkGeneric 02/2021
1	Methotrexate (Mexate)FDA LinkGeneric 02/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Cyclin D1IBA 01/2021
1	venetoclaxIBA 01/2021
1	liposomal doxorubicin (Doxil)FDA Link 12/2019
1	Fluorine-18IBA 02/2019
1	Bortezomib (Velcade)FDA Link 10/2016
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2016
1	Bendamustine Hydrochloride FDA Link 01/2016
1	Gemcitabine FDA Link 01/2016
1	posaconazole FDA Link 06/2015
1	Levofloxacin (Levaquin)FDA Link 05/2010

Therapy/Procedure

19	Therapeutics 02/2023 - 07/2002
17	Stem Cell Transplantation 01/2023 - 06/2006
15	Drug Therapy (Chemotherapy) 04/2023 - 07/2002
6	Highly Active Antiretroviral Therapy (HAART) 09/2020 - 12/2003
5	Radiotherapy 11/2023 - 08/2015
4	Transplantation 08/2009 - 07/2002
3	Salvage Therapy 01/2021 - 12/2003
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 08/2009 - 12/2003
2	Immunotherapy 01/2023 - 01/2022
2	Induction Chemotherapy 01/2020 - 01/2016
2	Hematopoietic Stem Cell Transplantation 10/2019 - 09/2005
1	Intravenous Infusions 02/2021
1	Autologous Transplantation 08/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2016
1	Cell Transplantation 12/2014
1	Hematopoietic Stem Cell Mobilization 11/2013
1	Central Venous Catheters 05/2010